We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
86 hedge funds and large institutions have $75.5M invested in Invesco Pharmaceuticals ETF in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 40 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.99% less ownership
Funds ownership: 26.36% → 25.37% (-0.99%)
8% less funds holding
Funds holding: 93 → 86 (-7)
25% less capital invested
Capital invested by funds: $101M → $75.5M (-$25.1M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
68% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 40
Holders
86
Holders Change
-7
Holders Change %
-7.53%
% of All Funds
1.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
40
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.29M |
| 2 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
+$588K |
| 3 |
5L
55I LLC
Boston,
Massachusetts
|
+$394K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$144K |
| 5 |
Morgan Stanley
New York
|
+$118K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$3.38M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.67M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.6M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.13M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$687K |
